Integrin alpha 4 beta 7/LPAM-1 Antibody (DATK32) [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-07899F
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
Flow Cytometry, Functional, Immunohistochemistry-Frozen, Immunoprecipitation
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Monoclonal Rat IgG2a Kappa Clone # DATK32
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
TK1 cells
Clonality
Monoclonal
Host
Rat
Isotype
IgG2a Kappa
Applications for Integrin alpha 4 beta 7/LPAM-1 Antibody (DATK32) [FITC]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Functional
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Frozen
Optimal dilutions of this antibody should be experimentally determined.
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Integrin alpha 4 beta 7/LPAM-1
Alternate Names
CD49d/beta7, LPAM-1, LPAM1
Gene Symbol
ITGA4
Additional Integrin alpha 4 beta 7/LPAM-1 Products
Product Documents for Integrin alpha 4 beta 7/LPAM-1 Antibody (DATK32) [FITC]
Product Specific Notices for Integrin alpha 4 beta 7/LPAM-1 Antibody (DATK32) [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...